Preliminary findings reported at AACR-NCI-EORTC from ongoing phase I studies of new GARFT inhibitor Oct. 31, 2001
Multitargeted antifolate has promising activity, good tolerability in pleural mesothelioma Oct. 30, 2001
RSS